Qiagen expands NGS portfolio with launch of QIAseq xHYB Long Read Panels

Qiagen (QGEN) announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enrichment solutions designed to unlock long-read sequencing of genomically complex regions. This new offering strengthens QIAGEN’s position as a provider of differentiated solutions for use on any next-generation sequencing platforms spanning both short- and long-read technologies. The new QIAGEN panels are optimized for use with native long-read platforms, including from PacBio (PACB), and designed to enable researchers to capture a broader spectrum of genomic variation. Applications include HLA typing, repeat expansion analysis, and the detection of structural variants – areas where short-read sequencing have been shown to have challenges. “This launch is a major milestone in our genomics strategy and reflects our long-term commitment to enabling cutting-edge science,” said Nitin Sood, Senior Vice President and Head of Product Portfolio & Innovation at QIAGEN. “We are making investments into our portfolio supporting NGS applications to expand the boundaries of what’s possible in areas like immune profiling, complex disease genetics and cancer biology. Our goal is to empower researchers with deeper genomic insights, but also to accelerate the translation of discoveries into future clinical applications.”